Quantitation of red cell‐bound immunoprotein
1998; Wiley; Volume: 38; Issue: 8 Linguagem: Inglês
10.1046/j.1537-2995.1998.38898375519.x
ISSN1537-2995
Autores Tópico(s)Blood disorders and treatments
ResumoTransfusionVolume 38, Issue 8 p. 782-795 Quantitation of red cell-bound immunoprotein R.J. Sokol DSc, MD, PhD, FRCP(Edin), FRCPath, Corresponding Author R.J. Sokol DSc, MD, PhD, FRCP(Edin), FRCPath Consultant HaematologistNational Blood Service, Trent Center, Longley Lane, Sheffield S5 7JN, UK.Search for more papers by this authorG. Hudson, G. Hudson George Hudson, DSc, MD, LLD, FRCP, FRCPath, Emeritus Professor of Haematology, University of Sheffield; and Honorary Member of Staff, National Blood Service, Trent Center, Sheffield.Search for more papers by this author R.J. Sokol DSc, MD, PhD, FRCP(Edin), FRCPath, Corresponding Author R.J. Sokol DSc, MD, PhD, FRCP(Edin), FRCPath Consultant HaematologistNational Blood Service, Trent Center, Longley Lane, Sheffield S5 7JN, UK.Search for more papers by this authorG. Hudson, G. Hudson George Hudson, DSc, MD, LLD, FRCP, FRCPath, Emeritus Professor of Haematology, University of Sheffield; and Honorary Member of Staff, National Blood Service, Trent Center, Sheffield.Search for more papers by this author First published: 27 February 2003 https://doi.org/10.1046/j.1537-2995.1998.38898375519.xCitations: 11 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Rosse WF. Quantitative immunology of immune hemolytic anemia. II. The relationship of cell-bound antibody to hemolysis and the effect of treatment. J Clin Invest 1971; 50: 734–43. 2 Van der Meulen FW, De Bruin HG, Goosen PC, et al. Quantitative aspects of the destruction of red cells sensitized with IgG1 autoantibodies: an application of flow cytofluorometry. Br J Haematol 1980; 46: 47–56. 3 Garratty G.. The significance of IgG on the red cell surface. Transfus Med Rev 1987; 1: 47–57. 4 Garratty G., Nance SJ. Correlation between in vivo hemolysis and the amount of red cell-bound IgG measured by flow cytometry. Transfusion 1990; 30: 617–21. 5 Sokol RJ, Hewitt S., Booker DJ, Stamps R.. Small quantities of erythrocyte bound immunoglobulins and autoimmune hemolysis. J Clin Pathol 1987; 40: 254–7. 6 Gilliland BC. Coombs-negative immune hemolytic anemia. Semin Hematol 1976; 13: 267–75. 7 Gilliland BC, Baxter E., Evans RS. Red-cell antibodies in acquired hemolytic anemia with negative antiglobulin serum tests. N Engl J Med 1971; 285: 252–6. 8 Sokol RJ, Hewitt S., Booker DJ, Bailey A.. Red cell autoantibodies, multiple immunoglobulin classes, and autoimmune hemolysis. Transfusion 1990; 30: 714–7. 9 Sokol RJ, Hewitt S., Booker DJ, Bailey A.. Erythrocyte autoantibodies, subclasses of IgG and autoimmune hemolysis. Autoimmunity 1990; 6: 99–104. 10 Sokol RJ, Hewitt S.. Autoimmune hemolysis: a critical review. CRC Crit Rev Oncol Hematol 1985; 4: 125–54. 11 Sokol RJ, Booker DJ, Stamps R.. The pathology of autoimmune haemolytic anaemia. Am J Clin Pathol 1992; 45: 1047–52. 12 Mackenzie MR. Monocyte sensitization in autoimmune hemolytic anemia (abstract). Clin Res 1975; 23: 132A. 13 Kay NE, Douglas SD. Monocyte-erythrocyte interaction in vitro in immune hemolytic anemias. Blood 1977; 50: 889–97. 14 Atkinson JP, Frank MM. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man. J Clin Invest 1974; 54: 339–48. 15 Munn LR, Chaplin H.. Rosette formation by sensitized human red cells—effects of source of peripheral leukocyte monolayers. Vox Sang 1977; 33: 129–42. 16 Frank MM, Hamburger MI, Lawley TJ, et al. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 1979; 300: 518–23. 17 Kelton JG. Impaired reticuloendothelial function in patients treated with methyldopa. N Engl J Med 1985; 313: 596–600. 18 Brojer E., Zupanska B., Michaleswska B.. Adherence to human monocytes of red cells from autoimmune haemolytic anaemia and red cells sensitized with alloantibodies. Haematologia 1982; 15: 135–45. 19 Fries LF, Brickman CM, Frank MM. Monocyte receptors for the Fc portion of IgG increase in number in autoimmune hemolytic anemia and other hemolytic states and are decreased by glucocorticoid therapy. J Immunol 1983; 131: 1240–5. 20 Gilliland BC, Leddy JP, Vaughan JH. The detection of cell-bound antibody on complement-coated human red cells. J Clin Invest 1970; 49: 898–906. 21 Rosse WF. Quantitative immunology of immune hemolytic anemia. I. The fixation of C1 by autoimmune antibody and heterologous anti-IgG antibody. J Clin Invest 1971; 50: 727–33. 22 Rosse WF. The quantitative antiglobulin consumption test. In: R. McMillan, ed. Immune cytopenias. New York: Churchill Livingstone, 1983: 177–96. 23 Fischer JT, Petz LD, Garratty G., Cooper NR. Correlations between quantitative assay of red cell-bound C3, serologic reactions, and hemolytic anemia. Blood 1974; 44: 359–73. 24 Kurlander RJ, Rosse WF, Logue GL. Quantitative influence of antibody and complement coating of red cells on monocyte-mediated cell lysis. J Clin Invest 1978; 61: 1309–19. 25 Kurlander RJ, Rosse WF. Monocyte-mediated destruction in the presence of serum of red cells coated with antibody. Blood 1979; 54: 1131–9. 26 Petz LD, Yam P., Wilkinson L., et al. Increased IgG molecules bound to the surface of red blood cells of patients with sickle cell anemia. Blood 1984; 64: 301–4. 27 Jeje MO, Blajchman MA, Steeves K., et al. Quantitation of red cell-associated IgG using an immunoradiometric assay. Transfusion 1984; 24: 473–6. 28 Van de Winkel JG, Tax WJ, Groeneveld A., et al. A new radiometric assay for the quantitation of surface-bound IgG on sensitized erythrocytes. J Immunol Methods 1988; 108: 95–103. 29 Kiruba R., Han P.. Quantitation of red cell-bound immunoglobulin and complement using enzyme-linked antiglobulin consumption assay. Transfusion 1988; 28: 519–24. 30 Atrah HI, Templeton JG, Crawford RJ, et al. Passive haemagglutination inhibition for quantitation of red cell associated IgG. Am J Clin Pathol 1987; 40: 494–9. 31 Szymanski IO, Araszkiewicz P.. Quantitative studies on the D antigen of red cells with the Du phenotype. Transfusion 1989; 29: 103–5. 32 Levitan N., Teno RA, Szymanski IO. An autoanalyzer test for the quantitation of platelet-associated IgG. Vox Sang 1986; 51: 127–32. 33 Burkart P., Rosenfield RE, Hsu TC, et al. Instrumented PVP-augmented antiglobulin tests. I. Detection of allogenic antibodies coating otherwise normal erythrocytes. Vox Sang 1974; 26: 289–304. 34 Hsu TC, Rosenfield RE, Burkart P., et al. Instrumented PVP-augmented antiglobulin tests. II. Evaluation of acquired hemolytic anemia. Vox Sang 1974; 26: 305–25. 35 Szymanski IO, Odgren PR, Fortier NL, Snyder LM. Red blood cell associated IgG in normal and pathologic states. Blood 1980; 55: 48–54. 36 Szymanski IO, Huff SR, Delsignore R.. An autoanalyzer test to determine immunoglobulin class and IgG subclass of blood group antibodies. Transfusion 1982; 22: 90–5. 37 Boursnell JC, Coombs RR, Rizk V.. Studies with marked anti-sera: quantitative studies with antisera marked with iodine 131isotope and their corresponding red-cell antigens. Biochem J 1953; 55: 745–57. 38 Costea N., Schwartz R., Constantoulakis M., Dameshek W.. The use of radioactive antiglobulin for the detection of erythrocyte sensitization. Blood 1962; 20: 214–32. 39 Constantoulakis M., Costea N., Schwartz RS, Dameshek W.. Quantitative studies of the effect of red-blood-cell sensitization on in vivo hemolysis. J Clin Invest 1963; 42: 1790–801. 40 Merry AH, Thompson EE, Rawlinson VI, Stratton F.. A quantitative antiglobulin test for IgG for use in blood transfusion serology. Clin Lab Haematol 1982; 4: 393–402. 41 Kajii E., Omi T., Miura Y., Ikemoto S.. A new approach for diagnosis of autoimmune hemolytic anemia. Jpn J Clin Hematol 1994; 35: 336–40. 42 Jenkins DE, Moore WH, Hawiger A.. A method for radioactive antiglobulin testing with 125I labelled anti-IgG. Transfusion 1977; 17: 16–22. 43 Salama A., Mueller-Eckhardt C.. Autoimmune haemolytic anaemia in childhood associated with non-complement binding IgM autoantibodies. Br J Haematol 1987; 65: 67–71. 44 Abdalla SH. Red cell associated IgG in patients suffering from Plasmodium falciparum malaria. Br J Haematol 1986; 62: 13–9. 45 Freedman J., Massey A.. Complement components detected on normal red blood cells taken into EDTA and CPD. Vox Sang 1979; 37: 1–8. 46 Freedman J., Massey A.. Quantitation of C3 subcomponents on red cells coated with complement in vitro. J Clin Pathol 1980; 33: 977–83. 47 Chaplin H., Nasongkla M., Monroe MC. Quantitation of red blood cell-bound C3d in normal subjects and random hospitalized patients. Br J Haematol 1981; 48: 69–78. 48 Freedman J., Barefoot C.. Red blood cell-bound C3d in normal subjects and in random hospital patients. Transfusion 1982; 22: 511–4. 49 LoBuglio AF, Vinocur L., Maglott JG, Court WS. Measurement of cell-associated IgG using monoclonal antibody. In: R. McMillan, ed. Immune cytopenias. New York: Churchill Livingstone, 1983: 214–23. 50 Merry AH, Thomson EE, Rawlinson VI, Stratton F.. The quantification of C3 fragments on erythrocytes: estimation of C3 fragments on normal cells, acquired haemolytic anaemia cases and correlation with agglutination of sensitized cells. Clin Lab Haematol 1983; 5: 387–97. 51 Shaw DR, Conley ME, Knox FJ, et al. Direct quantitiation of IgG subclasses 1, 2, and 3 bound to red cells by Rh1 (D) antibodies. Transfusion 1988; 28: 127–31. 52 Giles CM, Davies KA, Loizou S., et al. Quantification of IgG on erythrocytes of patients and normals by a radio-ligand-binding assay. Transfus Med 1991; 1: 223–8. 53 Giles CM, Davies KA, Walport MJ. In vivo and in vitro binding of C4 molecules on red cells: a correlation of numbers of molecules and agglutination. Transfusion 1991; 31: 222–8. 54 Merry AH. Quantitative aspects of the antiglobulin test for red cell-bound IgG, C3d and C3g. Biotest Bull 1986; 1: 53–8. 55 Gray LS, Masouredis SP. Interaction of 125I-protein A with erythrocyte-bound IgG. J Lab Clin Med 1982; 99: 399–409. 56 Yam P., Petz LD, Spath P.. Detection of IgG sensitization of red cells with 125I staphylococcal protein A. Am J Hematol 1982; 12: 337–46. 57 Gray LS, Kleeman JE, Masouredis SP. Differential binding of IgG anti-D and IgG autoantibodies to reticulocytes and red blood cells. Br J Haematol 1983; 55: 335–45. 58 Green GA, Rehn MM, Kalra VK. Cell-bound autologous immunglobulin in erythrocyte subspopulations from patients with sickle cell disease. Blood 1985; 65: 1127–33. 59 Green GA, Kalra VK. Sickling-induced binding of immunoglobulin to sickle erythrocytes. Blood 1988; 71: 636–9. 60 Salama A., Mueller-Eckhardt C., Bhakdi S.. A two-stage immunoradiometric assay with 125I-staphylococcal protein A for the detection of antibodies and complement on human blood cells. Vox Sang 1985; 48: 239–45. 61 Schreiber AB, Lambermont M., Strosberg AD, Wybran J.. A fluorometric assay for red blood cell antibodies. Transfusion 1981; 21: 178–83. 62 Garratty G.. Flow cytometry: its applications to immuno-haematology. Ballieres Clin Haematol 1990; 3: 267–87. 63 Garratty G., Arndt P.. Applications of flow cytofluorometry to transfusion science. Transfusion 1995; 35: 157–78. 64 Hadley AG, Zupanska B., Kumpel BM, et al. The glycosylation of red cell autoantibodies affects their functional activity in vitro. Br J Haematol 1995; 91: 587–94. 65 Kumpel BM, Judson PA. Quantification of IgG anti-D bound to D-positive red cells infused into D-negative subjects after intramuscular injection of monoclonal anti-D. Transfus Med 1995; 5: 105–12. 66 Lynen R., Neuhaus R., Schwarz DW, et al. Flow cytometric analyses of the subclasses of red cell IgG antibodies. Vox Sang 1995; 69: 126–30. 67 Arndt P., Garratty G.. Use of flow cytometry for detection of IgM on RBCs showing spontaneous agglutination (abstract). Transfusion 1994; 34(Suppl): 68S. 68 Garratty G., Arndt P., Domen R., et al. Severe autoimmune hemolytic anemia associated with IgM warm autoantibodies directed against determinants on or associated with glycophorin A. Vox Sang 1997; 72: 124–30. 69 Hadley AG, Zupanska B., Kumpel BM, et al. The functional heterogeneity of affinity-purified autoantibodies from patients with autoimmune haemolytic anaemia (abstract). Transfus Med 1993; 3(Suppl 1): 97. 70 Hadley AG, Zupanska B., Kumpel BM, et al. The glyco-sylation of IgG red cell autoantibodies affects Fcγ receptor III-mediated functional activity (abstract). Vox Sang 1994; 67(Suppl 2): 51. 71 Barker RN, Gruffydd-Jones TJ, Stokes CR, Elson CJ. Autoimmune hemolysis in the dog: relationship between anaemia and the levels of red blood cell bound immunoglobulines and complement measured by an enzyme-linked antiglobulin test. Vet Immunol Immunopathol 1992; 34: 1–20. 72 Bodensteiner D., Brown P., Skikne B., Plapp F.. The enzyme-linked immunosorbent assay: accurate detection of red blood cell antibodies in autoimune hemolytic anemia. Am J Clin Pathol 1983; 79: 182–5. 73 Bordin JO, Souza-Pinto JC, Kerbauy J.. Measurement of red blood cell antibodies in autoimmune hemolytic anemia. Braz J Med Biol Res 1991; 24: 895–9. 74 Bordin JO, Kerbauy J., Souza-Pinto JC, et al. Quantitation of red cell-bound IgG by an enzyme-linked antiglobulin test in human immunodeficiency virus-infected persons. Transfusion 1992; 32: 426–9. 75 Bruner KW, Kissling CW. An enzyme linked immunosorbent assay (ELISA) for detecting IgG sensitized erythrocytes. Transfusion 1979; 19: 773–7. 76 Greenwalt TJ, Dumaswala UJ, Siongco A., Domino MM. An enzyme-linked antiglobulin test to detect red cell globulins after glutaraldehyde fixation. Vox Sang 1992; 63: 268–71. 77 Hansen OP. Simultaneous quantification of red cell and platelet surface-bound IgG and IgM by an ELISA technique. Scand J Clin Lab Invest 1984; 44(Suppl 168): 45–55. 78 Hansen OP, Hansen TM, Jans H., Hippe E.. Red blood cell membrane-bound IgG: demonstration of antibodies in patients with autoimmune haemolytic anaemia and immune complexes in patients with rheumatic diseases. Clin Lab Haematol 1984; 6: 341–9. 79 Jones DR, Stokes CR, Gruffydd-Jones TJ, Bourne FJ. An enzyme-linked antiglobulin test for the detection of erythrocyte-bound antibodies in canine autoimmune haemolytic anaemia. Vet Immunol Immunopathol 1987; 16: 11–21. 80 Jones DR, Gruffydd-Jones TJ, Stokes CR, Bourne FJ. Use of a direct enzyme-linked antiglobulin test for laboratory diagnosis of immune-mediated hemolytic anemia in dogs. Am J Vet Res 1992; 53: 457–65. 81 Leikola J., Perkins HA. Enzyme-linked antiglobulin test: an accurate and simple method to quantify red cell antibodies. Transfusion 1980; 20: 138–44. 82 Postoway N., Nance SJ, Garratty G.. Variables affecting the enzyme-linked antiglobulin test when detecting and quantitating IgG red cell antibodies. Med Lab Sci 1985; 42: 11–9. 83 Namirska-Krzton H., Fabijanska-Mitek J., Seyfried H.. Enzyme-linked antiglobulin test for the evaluation of the amount of IgG autoantibodies on red blood cells. Clin Lab Haematol 1995; 17: 221–4. 84 Sheiban E., Gershon H.. The specific blocking of an IgG dependent erythrophagocytosis assay by protein G and ELISA determination of in situ bound IgG on erythrocytes of normal donors. J Immunol Methods 1990; 135: 139–46. 85 Sokol RJ, Hewitt S., Booker DJ, et al. An enzyme-linked direct antiglobulin test for assessing erythrocyte bound immunoglobulins. J Immunol Methods 1988; 106: 31–5. 86 Sokol RJ, Hewitt S., Booker DJ, Stamps R.. Enzyme linked direct antiglobulin tests in patients with autoimmune hemolysis. J Clin Pathol 1985; 38: 912–4. 87 Sokol RJ, Booker DJ, Stamps R.. Investigation of patients with autoimmune haemolytic anaemia and provision of blood for transfusion. J Clin Pathol 1995; 48: 602–10. 88 Rasmussen JM, Jepsen HH, Teisner B., et al. Quantification by ELISA of erythrocyte-bound C3 fragments expressing C3d and/or C3c epitopes in patients with Factor I deficiency and with autoimmune diseases. Vox Sang 1989; 56: 262–9. 89 Dale GL, Daniels RB. Quantitation of immunoglobulin associated with senescent erythrocytes from the rabbit. Blood 1991; 77: 1096–9. 90 Kumpel BM. A simple non-isotopic method for the quantitation of red cell-bound immunoglobulin. Vox Sang 1990; 59: 34–8. 91 Hazlehurst DD, Hudson G., Sokol RJ. A quantitative ELISA for measuring red cell-bound immunoglobulins. Acta Hematol 1996; 95: 112–6. 92 Dubarry M., Charron C., Habibi B., et al. Quantitation of immunoglobulin classes and subclasses of autoantibodies bound to red cells in patients with and without hemolysis. Transfusion 1993; 33: 466–71. 93 Hirano A., Yamada H., Kato K.. Quantitation of red-cell-bound IgG in normal and pathologic states by an enzyme immunoassay (EIA) technique. Nagoya J Med Sci 1984; 47: 5–16. 94 Thomas NC, Shirey RS, Blakemore K., Kickler TS. A quantitative assay for subclassing IgG alloantibodies implicated in hemolytic disease of the newborn. Vox Sang 1995; 69: 120–5. 95 Hamilton RG, Adkinson NF. Quantitative aspects of solid phase immunoassays. In: DM Kemeny, SJ Challacombe, eds. ELISA and other solid phase immunoassays: theoretical and practical aspects. New York: Wiley, 1988: 57–84. 96 Blick KE, Liles SM. Principles of clinical chemistry. New York: Wiley, 1985. 97 Garratty G.. Effect of cell-bound proteins on the in vivo survival of circulating blood cells. Gerontology 1991; 37: 68–94. 98 Stratton F., Rawlinson VI, Merry AH, Thomson EE. Positive direct antiglobulin test in normal individuals. II. Clin Lab Hematol 1983; 5: 17–21. 99 Garratty G.. The clinical significance (and insignificance) of red-cell-bound IgG and complement. In: ME Wallace, JS Levitt, eds. Current applications and interpretations of the direct antiglobulin test. Arlington: American Association of Blood Banks, 1988: 1–24. 100 Galili U., Korkesh A., Kahane I., Rachmilewitz EA. Demonstration of a natural antigalactosyl IgG antibody on thalassemic red blood cells. Blood 1983; 61: 1258–64. 101 Zupanska B., Brojer E., McIntosh J., et al. Correlation of monocyte-monolayer assay results, number of erythrocyte-bound IgG molecules, and IgG subclass composition in the study of red cell alloantibodies other than D. Vox Sang 1990; 58: 276–80. 102 Freedman J., Ho M., Barefoot C.. Red blood cell-bound C3d in selected hosptial patients. Transfusion 1982; 22: 515–20. 103 Merry AH, Thomson EE. The role of quantitative antiglobulin tests in immunohaematology; determination of the significance of erythrocyte-bound IgG; investigation of some parameters affecting the sensitivity of the antiglobulin test. Biotest Bull 1984; 2: 137–44. 104 Sokol RJ, Booker DJ, Stamps R.. Erythrocyte autoantibodies, autoimmune hemolysis, and carcinoma. Am J Clin Pathol 1994; 47: 340–3. 105 Alderman EM, Fudenberg HH, Lovins RE. Binding of immunoglobulin classes to subpopulations of human red blood cells separated by density-gradient centrifugation. Blood 1980; 55: 817–22. 106 Alderman EM, Fudenberg HH, Lovins RE. Isolation and characterization of an age-related antigen present on senescent human red blood cells. Blood 1981; 58: 341–9. 107 Freedman J.. Membrane-bound immunoglobulins and complement components on young and old red cells. Transfusion 1984; 24: 477–81. 108 Singer JA, Jennings LK, Jackson CW, et al. Erythrocyte homeostasis: antibody-mediated recognition of the senescent state by macrophages. Proc Natl Acad Sci USA 1986; 83: 5498–501. 109 Magnani M., Papa S., Rossi L., et al. Membrane-bound immunoglobulins increase during red blood cell aging. Acta Haematol 1988; 79: 127–32. 110 Kay MM. Drosophila to bacteriophage to erythrocyte: the erythrocyte as a model for molecular and membrane aging of terminally differentiated cells. Gerontology 1991; 37: 5–32. 111 Kay MM, Marchalonis JJ, Schluter SF, Bosman G.. Human erythrocyte aging: cellular and molecular biology. Transfus Med Rev 1991; 5: 173–95. 112 Gershon H.. Is the sequestration of aged erythrocytes mediated by natural autoantibodies? Isr J Med Sci 1992; 28: 818–28. 113 Gershon H.. Do natural autoantibodies play a role in physiologic red blood cell sequestration? Isr J Med Sci 1993; 29: 167–73. 114 Freedman J.. The significance of complement on the red cell surface. Transfus Med Rev 1987; 1: 58–70. 115 Roitt I., Brostoff J., Male D.. Immunology. 4th ed. London: Mosby, 1996. 116 Kaplan AP. The Hageman factor dependent pathways of human plasma. Microvasc Res 1974; 8: 97–111. 117 Gorst DW, Rawlinson VI, Merry AH, Stratton F.. Positive direct antiglobulin test in normal individuals. Vox Sang 1980; 38: 99–105. 118 Bareford D., Longster G., Gilks L., Tovey LA. Follow-up of normal inviduals with a positive antiglobulin test. Scand J Haematol 1985; 35: 348–53. 119 Rushton L., Booker DJ, Stamps R., Sokol RJ. Increasing frequency of positive direct anti-human globulin tests in blood donors (abstract). Transfus Med 1997; 7(Suppl 1): 22. 120 Sokol RJ, Hewitt S., Booker DJ. Erythrocyte autoantibodies, autoimmune hemolysis and myelodysplastic syndromes. J Clin Pathol 1989; 42: 1088–91. 121 Siegel I., Liu TL, Gleicher N.. The red-cell immune system. Lancet 1981; 2: 556–9. 122 Schifferli JA, Ng YC, Peters DK. The role of complement and its receptor in the elimination of immune complexes. N Engl J Med 1986; 315: 488–95. 123 Schifferli JA, Ng YC. The role of complement in the processing of immune complexes. Ballieres Clin Immunol Allergy 1988; 2: 319–34. 124 Halma C., Van Es LA, Daha MR. A newly discovered function of the erythrocyte: transport of immune complexes to the liver. Neth J Med 1992; 41: 245–54. 125 Jones DR, Scarsbrook AF, Imrie H., et al. Do plasma antiphospholipid anitbodies in patients with autoimmune haemolytic anaemia correlate with reduced levels of erythrocyte complement receptor I? Autoimmunity 1996; 23: 45–51. 126 Engelfriet CP, Von dem Borne AEGKr, Beckers DO, et al. Immune destruction of red cells. In: CA Bell, ed. A seminar on immune-mediated cell destruction. Chicago: American Association of Blood Banks, 1981: 93–130. 127 De Angelis V., De Matteis MC, Cozzi MR, et al. Abnormalities of membrane protein composition in patients with autoimmune haemolytic anaemia. Br J Haematol 1996; 95: 273–7. 128 Garratty G.. The significance of complement in immunohematology. CRC Crit Rev Clin Lab Sci 1989; 20: 25–56. 129 Merry AH, Thompson EE, Rawlinson VI, Stratton F.. Quantitation of IgG on erythrocytes: correlation of number of IgG molecules per cell with the strength of the direct and indirect antiglobulin tests. Vox Sang 1984; 47: 73–81. 130 Rosse WF. The detection of small amounts of antibody on the red cell in autoimmune hemolytic anemia. Ser Haematol 1974; 7: 358–66. 131 Zupanska B., Thomson EE, Merry AH. Fc receptors for IgG1 and IgG3 on human mononuclear cells—an evaluation with known levels of erythrocyte-bound IgG. Vox Sang 1986; 50: 97–103. 132 Economidou J., Hughes-Jones NC, Gardner B.. Quantitative measurements concerning A and B antigen sites. Vox Sang 1967; 12: 321–8. 133 Economidou J., Hughes-Jones NC, Gardner B.. The functional activities of IgG and IgM anti-A and anti-B. Immunology 1967; 13: 227–34. 134 Sokol RJ, Booker DJ, Stamps R., et al. AIHA due to warm reacting IgM class antibodies (abstract). Transfus Med 1996; 6(Suppl 2): 22. 135 Sokol RJ, Booker DJ, Stamps R.. Evidence that warm IgM erythrocyte autoantibodies can cause haemolysis independently of complement (abstract). Transfus Med 1992; 2 (Suppl 1): 79. 136 Sokol RJ, Booker DJ, Stamps R., et al. IgA red cell autoantibodies and autoimmune hemolysis. Transfusion 1997; 37: 175–81. 137 Sokol RJ, Booker DJ, Stamps R., et al. Severe autoimmune haemolytic anaemia (AIHA) due to strong IgA class autoantibodies showing Rh specificity (abstract). Transfus Med 1994; 4(Suppl 1): 47. 138 Sokol RJ, Booker DJ, Stamps R., Booth JR. Autoimmune hemolytic anemia due to IgA class autoantibodies. Immunohematology 1996; 12: 14–9. 139 Zupanska B., Brojer E., Thomson EE, et al. Monocyte-erythrocyte interaction in autoimmune haemolytic anaemia in relation to the number of erythrocyte-bound IgG molecules and subclass specificity of autoantibodies. Vox Sang 1987; 52: 212–8. 140 Zupanska B., Thompson E., Brojer E., Merry AH. Phagocytosis of erythrocytes sensitised with known amounts of IgG1 and IgG3 anti-Rh antibodies. Vox Sang 1987; 53: 96–101. 141 Zupanska B., Sokol RJ, Booker DJ, Stamps R.. Erythrocyte autoantibodies, the monocyte monolayer assay and in vivo hemolysis. Br J Haematol 1993; 84: 144–50. 142 Zupanska B.. Rosetting, phagocytosis and immune red cell damage. Clin Lab Haematol 1990; 12: 309–20. 143 De Giorgi L., Podberezin M., Booker DJ, Sokol RJ. A chemiluminescence test for predicting the presence and severity of autoimmune haemolysis (abstract). Transfus Med 1996; 6(Suppl 2): 23. 144 Podberezin M., De Giorgi L., Booker DJ, et al. Evaluation of red cell autoantibodies in patients with primary and secondary autoimmune haemolysis using a chemiluminescence test (abstract). Transfus Med 1996; 6(Suppl 2): 23. 145 Mazza G., Day MJ, Barker RN, et al. Quantitation of erythrocyte-bound IgG subclass autoantibodies in murine autoimmune haemolytic anaemia. Autoimmunity 1996; 23: 245–55. 146 Perry FE, Barker RN, Mazza G., et al. Autoreactive T cell specificity in autoimmune hemolytic anemia of the NZB mouse. Eur J Immunol 1996; 26: 136–41. Citing Literature Volume38, Issue8August 1998Pages 782-795 ReferencesRelatedInformation
Referência(s)